University of Osaka researchers used genome editing to program mouse liver cells to produce exenatide, a weight-loss drug.

Weight-loss drugs have surged in popularity, promising rapid results with regular injections. Now, researchers from Japan ...

Would you get a one-time genetic modification such that you'd never have to take a GLP-1 drug for weight loss ever again?

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

Researchers create a one-time genome editing introducing a GLP-1 receptor agonist, resulting in long-term appetite ...

Adults with type 1 diabetes on multiple daily injection therapy saw no benefit in glycemic measures when adding on preprandial injections of short-acting exenatide, according to findings from a ...

Weight-loss drugs have surged in popularity, promising rapid results with regular injections. Now, researchers from Japan report a way ...

GLP-1 RAs are associated with a modestly increased risk for GERD and gallstone disease but not with GI and biliary complications.

Mouse livers were engineered via a one-time genome editing to secrete a GLP-1, cutting weight gain and improving glucose ...